Sorafenib Tosylate
Specifications
475207-59-1CAS Number
641-758-8EC Number
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acidIUPAC Name
C28H24ClF3N4O6SChemical Formula
637 g/molMolecular Weight
Sorafenib tosylate; 475207-59-1; Sorafenib tosilate; DTXSID9047839; BAY 54-9085; 5T62Q3B36J; NSC724772; BAY-54-9085; BAY 43-9006 tosylate; DTXCID9027817; CHEBI:50928; 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)urea mono(4-methylbenzenesulfonate); 4-(4-(((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)AMINO)PHENOXY)-N-METHYLPYRIDINE-2-CARBOXAMIDE 4-METHYLBENZENESULFONATE; 1-[4-Chloro-3-(trifluoromethyl)phenyl]-3-[4-[[2-(methylcarbamoyl)pyridin-4-yl]oxy]phenyl]urea mono(4-methylbenzenesulfonate); 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide 4-methylbenzenesulfonate; RefChem:57444; 4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic Acid Methyamide-4-methylbenzenesulfonate Tosylate; 641-758-8; 4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate; Nexavar; Sorafenib tosylate [USAN]; MFCD08235032; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N2-methylpyridine-2-carboxamide mono (4-methylbenzenesulfonate); Sorafenib (Tosylate); Sorafenib Hemitosylate; s1040; 2056030-06-7; Sorafenib tosilate (JAN); Sorafenib (Nexavar); Sorafenib tosylate (USAN); Nexavar(R); 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide 4-methylbenzenesulfonate; SORAFENIB TOSILATE [JAN]; MLS002415564; CAS-475207-59-1; NSC-724772; 475207-59-1 (tosylate); NCGC00167488-01; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid; SMR001339079; C28H24ClF3N4O6S; UNII-5T62Q3B36J; SR-00000000529; orafenib tosylate; Sorafenib CRS; BAY43-9006 mono-p-tosylate; BAY 43-9006 mono-p-tosylate; Nexavar (TN); Sorafenib tosilate CRS; SCHEMBL162935; orb1310945; SORAFENIB TOSYLATE [MI]; CHEMBL1200485; SCHEMBL29919725; Sorafenib (Tosylate) (Standard); Sorafenib tosylateBay 43-9006; GLXC-90155; HMS2219E08; HMS3654I09; HMS5079C07; HY-10201AR; Sorafenib (BAY-43-9006)?; SORAFENIB TOSILATE [MART.]; SORAFENIB TOSILATE [WHO-DD]; SORAFENIB TOSYLATE [USP-RS]; Tox21_112489; EBC-17173; HY-10201A; AKOS015924650; AKOS027469919; Tox21_112489_1; AC-6799; CCG-208000; CS-0164; FS10808; ND-0228; Sorafenib tosylate - Bio-X trade mark; SORAFENIB TOSYLATE [ORANGE BOOK]; NCGC00167488-08; SORAFENIB TOSILATE [EP MONOGRAPH]; 2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-, mono(4-methylbenzenesulfonate); 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide 4-methylbenzenesulfonate.; BS164414; SORAFENIB TOSYLATE [USP MONOGRAPH]; SY012324; SW202562-3; D06272; S-8502; SR-00000000529-5; Q27122250; 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide tosylate; -(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N2-methylpyridine-2-carboxamide mono (4-methylbenzenesulfonate); 4-(4-(((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)AMINO)PHENOXY)-N-METHYLPYRIDINE-2-CARBOXAMIDE 4-METHYLBENZENESULPHONATE; 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide4-methylbenzenesulfonate; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-methylbenzene-1-sulfonic acid; 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-2-pyridinecarboxamide Tosylate; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide;4-methylbenzenesulfonic acid; 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide tosylate; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;hydron;4-methylbenzenesulfonate; 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)-amino]phenoxy}-N-methylpyridine-2-carboxamide tosylate; 4-{4-[({[4-Chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N -methylpyridine-2-carboxamide tosylate; 4-{4-[({[4-Chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide tosylate; 4-{4-[3-(4-Chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy} -pyridine-2-carboxylic acid methylamide-4-methylbenzenesulfonate; 4-{4-[3-(4-Cl-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid methylamide 4-methylbenzenesulfonate; 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide monomethanesulfonate; 4-Methylbenzene-1-sulfonic acid--4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide (1/1); Sorafenib Tosylate MicronizedSynonyms
Products Containing Sorafenib Tosylate
소라닙정200밀리그램(소라페닙토실레이트(미분화))넥사바정200밀리그램(소라페닙토실레이트(미분화))NEXAVAR 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULASORAFENIB VIATRIS 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGSORAFENIB TEVA 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGSORAFENIB EUGIA 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGSORAFENIB ACCORD 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGSORAFENIB STADA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULASORAFENIB STADA 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGSORAFENIB DR. REDDYS 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGNEXAVAR 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULASORAFENIB ZENTIVA 200 mg, comprimé pelliculé
Page 1 of 4
Companies Selling Sorafenib Tosylate
한미
한미약품(주)Republic of KoreaBS
Bayer South East Asia Pte LtdSingaporeCC
Chongqing Carelife PharmaceuticalChinaHD
Hangzhou Dingyan Chem Co., LtdChinaSI
Sinoway Industrial Co.Ltd.ChinaKP
Kinhoo Pharmaceutical Co., Ltd.ChinaSD
SHIJIAZHUANG DINGMIN PHARMACEUTICAL SCIENCES CO., LTDChinaAH
Anhui Haikang Pharmaceutical Co., Ltd.ChinaWH
Wuxi Hexia Chemical CompanyChinaPage 1 of 3